Vanguard Group Inc Repare Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 54,265 shares of RPTX stock, worth $68,373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,265
Previous 55,097
1.51%
Holding current value
$68,373
Previous $189,000
62.43%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RPTX
# of Institutions
59Shares Held
33.6MCall Options Held
51KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$13 Million0.51% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.34 Million1.93% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.19 Million0.12% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.74 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.33 Million5.13% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $52.8M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...